Robust and stable immediate release formulation of candesartan cilexetil , bcs class iv drug and its statistical optimization

• In: Dissolution/In Vitro Release Performance Testing- Posters
• At: Istanbul (Turkey) (2009)
• Type: Poster
• Poster code: DIV-P-001
• By: KOHLI, Kanchan (D/o Pharmaceutics, F/o Pharmacy, Jamia Hamdard University, New Delhi, India)
• Co-author(s): Kumar, Ramesh (D/o Pharmaceutics, F/o Pharmacy, Jamia Hamdard University, NEW DELHI, India)
  Garg, Abhinav (D/o Pharmaceutics, F/o Pharmacy, Jamia Hamdard University, NEW DELHI, India)
  Kumar, Anoop (D/o Pharmaceutics, F/o Pharmacy, Jamia Hamdard University, NEW DELHI, India)
  
• Abstract:

  Candesartan cilexetil (C.C), a selective AT I Antagonist indicated for Hypertension. This potent prodrug poses great challenges to formulators as it falls in Bio classification system (BCS) class IV and hence has a limitation of poor bioavailability and bioequivalence. Present research work aimed at developing a statistically optimized immediate..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login